Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.
| Period | Ended | Value | Kind | Source trail |
|---|
NeuroSense Therapeutics Ltd. · CIK 1875091 · Engraved from SEC EDGAR
FY2025 figures · derived
NeuroSense Therapeutics Ltd. is the 287th largest of the 566 covered companies the SEC files under this code, by market cap. SIC 2834
Latest filing Oct 2, 2026
The ifrs-full concepts with the most facts on file for this company.
Peers are the covered companies filed under the same SIC code, then under codes that share its first three digits or its first two, nearest in market cap first. Figures are each company’s latest fiscal year as filed; market cap is at its latest price.
| Fiscal year | Dividends | Buybacks | Total | Per share | Shares | Shares · yoy | of free cash flow |
|---|---|---|---|---|---|---|---|
| FY2023 | $310.00K | — | $310.00K | — | 15.38M sh | — | — |
| FY2022 | $310.00K | — | $310.00K | — | — | — | — |
| FY2021 | $29.00K | — | $29.00K | — | 10.94M sh | — | — |
| FY2020 | $28.00K | — | $28.00K | — | — | — | — |
| FY2019 | $27.00K | — | $27.00K | — | — | — | — |